Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement
<p>Abstract</p> <p>Background</p> <p>Patients undergoing elective total hip replacement (THR) surgery are at an increased risk for venous thromboembolic events (VTEs). Dalteparin and enoxaparin are recommended as thromboprophylaxis for at least 10 days in these patients...
Main Authors: | Choe Yoonhee, Jelincic Valentina, Dranitsaris George |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | Thrombosis Journal |
Online Access: | http://www.thrombosisjournal.com/content/9/1/3 |
Similar Items
-
Management of venous thromboembolism in patients with cancer: role of dalteparin
by: Lori-Ann Linkins
Published: (2008-04-01) -
Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin
by: Wael A. Rahman, et al.
Published: (2020-07-01) -
Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis
by: Dranitsaris G, et al.
Published: (2017-01-01) -
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
by: Levitan B, et al.
Published: (2014-03-01) -
Cost-Effectiveness of Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Adult Patients Undergoing Elective Hip or Knee Replacement Surgery in Portugal
by: José Roxo Neves, et al.
Published: (2014-01-01)